Sexual and reproductive health

Progestogen-only contraceptive use during lactation and its effects on the neonate

Statement

Share

Authors:
World Health Organization, Department of Reproductive Health and Research

Progestogen-only contraceptive use during lactation and its effects on the neonate. Statement

Publication details

Number of pages: 2
Publication date: 2009
Languages: English
WHO reference number: WHO/RHR/09.13 - Web only

Downloads

On 22 October 2008, a technical consultation to evaluate the evidence surrounding hormonal contraceptive use during lactation and its effects on the neonate considered the safety of contraceptive use in both the mother and her breastfed child.

Discussions focused on the importance of balancing the benefits of a mother starting to use contraception during the first 6 weeks postpartum, when breastfeeding women are not at risk for pregnancy, with any potential risks to her infant. The consultation concentrated on the effects of exposure to hormonal contraceptives upon the development of the infant brain, where the theoretical risks to the child are the greatest.